ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX) announced today the issuance of 14 new patents covering a wide range of the core technologies of BioTime and its subsidiaries Asterias Biotherapeutics, Inc. (NYSE MKT: AST), OrthoCyte Corporation, ES Cell International Pte Ltd, OncoCyte Corporation, and ReCyte Therapeutics, Inc. The new patents issued over Q3 and […]
Genedata Announces Strong Adoption of High Content Screening in Pharma R&D Running Genedata Screener
San Diego, Calif. — Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that 75% of pharmaceutical companies running Genedata Screener® have adopted Genedata Screener for HCS for their phenotypic screening and other image-based screening projects. Extending the Genedata Screener platform, Genedata Screener for HCS streamlines workflow […]
Tokyo, Japan and Livingston, NJ, USA — Nanion is expanding on two continents as new state-of-the-art research and demonstration facilities are opened in Tokyo, Japan and Livingston, NJ, USA. The new facilities provide the opportunity for customers to see Nanion’s entire product portfolio in action, from the Port-a-Patch to the SyncroPatch 384/768PE. USA 306x288Nanion Technologies, […]
PicoQuant has released version 2.0 of its SymPhoTime 64 FLIM and FCS software package. New features include global analysis of FCS and TCSPC curve fitting, which especially improves cell measurements, as well as STED data acquisition and analysis procedures, e.g., gatedSTED, resolution estimation*. An extended TCSPC binning functionality permits faster analysis and binary export of […]
Madrid, Spain and Heidelberg, Germany -– SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the global launch of TruePrime™ Single Cell WGA kit, the first product of its TruePrime™ product line for whole genome amplification (WGA) from single cells. With the TruePrime™ Single Cell WGA kit, SYGNIS opens up a series of product […]
Maynard, MA –- CHI Scientific, Inc., an innovator in the field of cell culture, today announced the release of PrimaCell™ protocols for culturing more than 300 types of primary cells that will enable scientists to overcome the variability of experimental results derived from today’s individualized time-consuming procedures. These bench-proven protocols developed for PrimaCell? cell culture […]
SOUTH SAN FRANCISCO, Calif. –– Fluidigm Corporation (NASDAQ:FLDM) today announced total revenue for the fourth quarter of 2014 is expected to be approximately $33.4 million based on preliminary, unaudited financial data. Organic revenue for the fourth quarter of 2014 (excluding revenue attributable to the DVS Sciences acquisition, comprised of the CyTOF® 2 system and proteomics […]
SAN BRUNO, Calif. and MADISON, Wis. — Cord Blood Registry® (CBR®) and Cellular Dynamics International (NASDAQ:ICEL) (CDI) announced today that they have entered into a research collaboration to reprogram newborn stem cells from both umbilical cord blood and umbilical cord tissue collected, processed and cryopreserved under CBR’s protocols into induced pluripotent stem cells (iPSCs) using […]
Billerica, MA -– Seahorse Bioscience, the industry leader in metabolic analyzers and assay kits for measuring real time cell metabolism, reached its 500th citation in a scientific journal for the year 2014 in a paper published in Nature Medicine, November 24, 2014. The paper, “Chronic Enrichment of Hepatic Endoplasmic Reticulum-Mitochondria Contact Leads to Mitochondrial Dysfunction […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today introduced the GenetiSure Pre-Screen Kit, a high-throughput oligonucleotide microarray for screening aneuploidy and other genomic aberrations in the 5- to 10-Mb range from single cells in three- and five-day embryos. Agilent’s kit allows for a turnaround time of less than eight hours from DNA extraction […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
